Back
ZoomInfo Technologies Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
30
ZI
ZoomInfo Technologies
Last Price:
$10.84
Seasonality Move:
-12.97%
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$270.89
Seasonality Move:
7.6%
Sell
30
ZoomInfo Technologies (ZI)
is a Sell
Is ZoomInfo Technologies a Buy, Sell or Hold?
-
The current ZoomInfo Technologies [ZI] share price is $11.03. The Score for ZI is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ZI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $269.21. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ZI Stock Price Chart
What is ZoomInfo Technologies's stock price today?
-
The ZoomInfo Technologies share price today is $11.03The current trend is moderately bullish and ZI is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $269.21Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
ZI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 53.58 | Buy |
| Chaikin Money Flow: | -3235931 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.25 - 11.59) | Buy |
| Bollinger Bands (100): | (10.04 - 11.34) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.33 | Buy |
| Relative Strength Index (14 RSI): | 56.44 | Buy |
| Chaikin Money Flow: | -958699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (238.07 - 265.67) | Buy |
| Bollinger Bands (100): | (240.5 - 271.04) | Buy |
ZI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.84 | Buy |
| 20-day SMA: | 11.16 | Sell |
| 50-day SMA: | 10.52 | Buy |
| 200-day SMA: | 10.71 | Buy |
| 8-day EMA: | 10.94 | Buy |
| 20-day EMA: | 10.88 | Buy |
| 50-day EMA: | 10.72 | Buy |
| 200-day EMA: | 11.51 | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 266.08 | Buy |
| 20-day SMA: | 252.48 | Buy |
| 50-day SMA: | 259.02 | Buy |
| 200-day SMA: | 252.75 | Buy |
| 8-day EMA: | 268.02 | Buy |
| 20-day EMA: | 259.47 | Buy |
| 50-day EMA: | 256.9 | Buy |
| 200-day EMA: | 244.06 | Buy |
ZoomInfo Technologies Earnings Growth & ZI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.03 per share, and an increase next year of $0.03 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
ZoomInfo Technologies Technical Analysis
| Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||